Home Page | XELJANZ® (tofacitinib) For UC

Adult patients with moderately to severely active UC were evaluated in clinical trials. Some patients in the clinical studies were taking background medicines and some were not. All patients in the studies had tried other medicines such as corticosteroids, azathioprine, or TNF blockers that did not work well or could not be tolerated. XELJANZ is approved for use in patients when TNF blockers did not work well or could not be tolerated.
Explore Clinical Trial Results

Discussing UC

No matter how long you’ve had UC, talking about it can feel awkward and embarrassing, even when the conversation is with your gastroenterologist (GI). Don’t hold back. Your GI is prepared for conversations like these. It’s important that you have an open and honest discussion about your UC symptoms. Every appointment is an opportunity to improve the dialogue with your GI and discuss how to manage your UC.
Ready to make an appointment? Find A Healthcare Provider near you.

Prepare

Write down any questions or concerns you have ahead of your appointment. This can help make the conversation easier and give your doctor a more complete picture of your symptoms.

Share

When you’re with your GI or another member of your healthcare team, you may feel uncomfortable talking, but it’s important that you share. The information you share with your doctor could be helpful in finding a treatment plan that may work best for you.

Align

Communicate with your healthcare team to help them understand your goals, concerns, and expectations. This conversation will be useful in getting everyone on the same page.

View Doctor Discussion Guide

Leave a Reply